Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C)

K-Number: K952260 · 1996-01-03

ApplicantStellar Contact Lens, Inc.
Decision Date1996-01-03
Product CodeHQD
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C) is the device name listed in this FDA 510(k) record. The listed applicant is Stellar Contact Lens, Inc.. It received FDA 510(k) clearance on 1996-01-03 under 510(k) number K952260. The device is classified under product code HQD. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C)?

OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C) is a medical device that received FDA 510(k) clearance on 1996-01-03. The listed applicant is Stellar Contact Lens, Inc.. The 510(k) number is K952260.

When did OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C) receive FDA 510(k) clearance?

OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C) received FDA 510(k) clearance on 1996-01-03, under 510(k) number K952260.

Who is the listed applicant for OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C)?

The FDA 510(k) record lists Stellar Contact Lens, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C)?

The FDA product code for OP-2 (LOTIFOCON B) & OP-6 (LOTIFOCON C) is HQD.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Related Devices (Code: HQD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253822GPA (hexafocon A) Rigid Gas Permeable Contact LensesZhuhai Fitlens Medical Technology Co., Ltd.K242393Acuity 181™ (tisilfocon A) and Acuity 181™ (tisilfocon A) with Tangible™ Hydra-PEG® Rigid Gas Permeable Contact LensesAcuity Polymers, Inc.K241398SDJMASTERVISION (fluoroxyfocon A) Rigid Gas Permeable Contact LensesTianjin Mastervision Technology Co., Ltd.K241571BostonSight® Specialty LensesBoston Foundation For Sight, Inc. D/B/A BostonsightK240618Acuity 200™ (fluoroxyfocon A) Rigid Gas Permeable Contact Lens; Acuity 100™ (hexafocon A) Rigid Gas Permeable Contact Lens; Acuity 200™ with Tangible® Hydra-PEG® (fluoroxyfocon A) Rigid Gas Permeable Contact Lens; Acuity 100™ with Tangible® Hydra-PEG® (hexafocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc.K233325Visionary Optics Scleral Contact Lens (roflufocon D, roflufocon E, hexafocon A, hexafocon B, tisilfocon A, fluoroxyfocon A)Visionary Optics, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑